HAA-09, an orally administered compound, serves as a powerful anti-influenza agent by targeting the influenza PB2_cap binding domain. It possesses significant activity against influenza A virus, exhibiting an EC50 of 0.03 µM, and demonstrates polymerase
Molekulargewicht:
376.36
CAS Nummer:
[1422051-33-9]
Formel:
C17H18F2N6O2
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
